Skip to main content

Table 1 Anthropometric measurements and metabolic analysis of the population studied

From: Adipo/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque

  Serum group of healthy subjects Coronary patients with non-atherosclerotic mammary artery Unstable carotid atherosclerotic plaque group
(n = 16) (n = 13) (n = 18)
Mean ± SD Mean ± SD Mean ± SD
Age (years) 52.47 ± 13.25 65.08 ± 10.48 69.17 ± 7.44b
BMI (kg/m2) 32.19 ± 11.76 29.39 ± 3.36 27.74 ± 3.13
Glucose (mg/dl) 91.31 ± 14.24 129.19 ± 55.44a 123.56 ± 45.37b
HbA1c (%) 4.97 ± 0.39 6.81 ± 1.39a 6.29 ± 1.07b
Insulin (mUI/L) 12.76 ± 16.19 11.76 ± 7.15 7.21 ± 4.93
HOMA2-IR 1.62 ± 1.95 1.59 ± 0.97 1.01 ± 0.67
Triglycerides (mg/dL) 115.02 ± 71.38 110.33 ± 27.84 103.00 ± 40.61
Cholesterol (mg/dl) 192.33 ± 37.81 128.34 ± 23.92a 118.81 ± 34.54b
HDL-C (mg/dL) 49.13 ± 10.35 23.71 ± 4.64a 28.50 ± 6.98b
LDL-C (mg/dL) 120.17 ± 39.06 78.56 ± 19.48a 69.78 ± 26.21b
  1. Subjects were classified according to the samples obtained: serum group of healthy subjects (n = 16), non-atherosclerotic mammary artery samples from patients undergoing coronary artery bypass (n = 13) and unstable carotid atherosclerotic plaque samples from patients undergoing endarterectomy (n = 18). BMI body mass index, HbA1c glycosylated haemoglobin, HOMA2-IR homeostatic model assessment 2- insulin resistance, HDL-C high density lipoprotein, LDL-C low density lipoprotein. Data are expressed as mean ± SD. p <0.05 are considered statistically significant. arefer to the statistically significant differences between coronary patients with non-atherosclerotic mammary artery and serum group of healthy subjects. brefer to the statistically significant differences between unstable carotid plaque and serum group of healthy subjects. HOMA-2 is calculated using the HOMA Calculator version 2.2.2 (http://www.dtu.ox.ac.uk)